{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/OSG/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T00:13:09.501Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10771,"canonical_name":"OCTAVE SPECIALTY GROUP INC","cik":"0000874501","uei":null,"lei":null,"duns":null,"ticker":"OSG"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":13},"count":13,"timeline":[{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — OCTAVE SPECIALTY GROUP INC — 2026-08-06","url_slug":"/sec/cik-0000874501/10-q/0001628280-26-054446","accession_number":"0001628280-26-054446","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — OCTAVE SPECIALTY GROUP INC — 2026-08-06","url_slug":"/sec/cik-0000874501/8-k/0001628280-26-054440","accession_number":"0001628280-26-054440","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"S-8","title":"S-8 — OCTAVE SPECIALTY GROUP INC — 2026-08-06","url_slug":"/sec/cik-0000874501/s-8/0001628280-26-054482","accession_number":"0001628280-26-054482","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — OCTAVE SPECIALTY GROUP INC — 2026-08-06","url_slug":"/sec/cik-0000874501/s-8-pos/0001628280-26-054475","accession_number":"0001628280-26-054475","importance":30},{"ts":"2026-07-09","kind":"sec.insider.f","reporter":"LeBlanc Claude","title":"Chief Executive Officer","shares":21777,"price_per_share":6.08,"usd_value":132404,"security_title":"Common Stock","importance":15.13240416},{"ts":"2026-07-09","kind":"sec.insider.f","reporter":"Trick David","title":"Exec VP, CFO & Treasurer","shares":6741,"price_per_share":6.08,"usd_value":40985,"security_title":"Common Stock","importance":15.04098528},{"ts":"2026-07-09","kind":"sec.insider.f","reporter":"Smith R Sharon","title":"Exec VP & Group COO","shares":4635,"price_per_share":6.08,"usd_value":28181,"security_title":"Common Stock","importance":15.0281808},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Smith R Sharon","title":"Exec VP & Group COO","shares":11779,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"LeBlanc Claude","title":"Chief Executive Officer","shares":39380,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Trick David","title":"Exec VP, CFO & Treasurer","shares":13206,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — IGLESIAS LISA G — 2026-07-07","url_slug":"/sec/cik-0001103172/4/0001628280-26-047521","accession_number":"0001628280-26-047521","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — OCTAVE SPECIALTY GROUP INC — 2026-05-14","url_slug":"/sec/cik-0000874501/defa14a/0001628280-26-035119","accession_number":"0001628280-26-035119","importance":30},{"ts":"2026-05-11","kind":"sec.13dg","reporter":"Western Standard LLC","shares":2247591,"percent_of_class":4.99,"security_title":"SCHEDULE 13G/A","accession_number":"0001193125-26-217323","excerpt":null,"importance":55}]}